2018 Volume 4 Issue 1 Pages 25-27
A patient was 42–years–old woman with right–sided facial palsy caused by varicella–zoster virus (VZV). The facial palsy was severe and was 6 points on Yanagihara score on day 4. Oral prednisolone, valacyclovir, and mecobalamin were started and facial palsy was 12 points on Yanagihara score on day 13. Keishikajutsubuto was started and facial palsy was improved, was 32 points on Yanagihara score on day 20 and 40 points on day 41. There is no report that keishikajutsubuto effective for facial palsy caused by VZV. In conclusion, there is a possibility that keishikajutsubuto is a useful option for the treatment of facial palsy caused by VZV.